Lung cancer comes in two main types: non-small cell and small cell. Each has different patterns, growth rates, and treatment needs. Smoking is the top risk factor, but…
Harry Erba, MD, PhD, Duke University, Durham, NC; Marina Konopleva, MD, PhD, Albert Einstein College of Medicine, New York City, NY; Thomas Cluzeau, MD, PhD, Central University Hospital…
NEW YORK (Reuters Health) – The clinical spectrum of intracranial hemorrhage was similar in patients treated with warfarin or dabigatran in the pivotal RE-LY trial, a new analysis…
NEW YORK (Reuters Health) – In locally advanced or metastatic prostate cancer, intermittent androgen deprivation (IAD) is a “feasible, efficient and safe” alternative to continuous androgen deprivation (CAD)…
NEW YORK (Reuters Health) – Patients having coronary artery bypass grafting (CABG) have fewer postoperative heart rhythm complications and recover faster if they are pretreated with a statin,…
NEW YORK (Reuters Health) – When testing indicates fetal lung immaturity at 34 weeks’ gestation or more, administration of antenatal corticosteroids does not reduce respiratory problems in the…
NEW YORK (Reuters Health) – In the setting of primary percutaneous coronary intervention for ST segment-elevated MI, use of drug-eluting stents (DES) rather bare metal stents (BMS) is…
NEW YORK (Reuters Health) – Progression-free survival (PFS) is significantly longer in women with recurrent ovarian cancer when bevacizumab is added to chemotherapy, a multicenter team reports in…
NEW YORK (Reuters Health) – A combined oral contraceptive containing nomegestrol acetate and 17beta-estradiol (E2) taken in a 24–4-day regimen is somewhat more effective in preventing pregnancy than…
NEW YORK (Reuters Health) – Patients with NYHA class II heart failure are less likely to develop atrial fibrillation or flutter when given eplerenone, according to findings appearing…
NEW YORK (Reuters Health) – Despite a guideline in Canada recommending the use of opioids to relieve refractory dyspnea in COPD patients, physicians there are reluctant to do…
NEW YORK (Reuters Health) – Cancer patients given pegfilgrastim experience less bone pain if they take naproxen 500 mg twice daily for about a week, according to the…
